A retrospective study of characteristics and treatment patterns of Danish VTE patients receiving rivaroxaban and apixban
Latest Information Update: 25 Jan 2022
At a glance
- Drugs Apixaban (Primary) ; Rivaroxaban (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 03 Jul 2021 New trial record
- 17 May 2021 Results presented at the 70th Annual Scientific Session of the American College of Cardiology